Bob Hoffman (Vice Chair)
Bob Hoffman is AAM Vice Chair and Chief Commercial Officer of US Generics for Lupin Pharmaceuticals, Inc. In this role, he is responsible for executing the strategic direction of the business and all of the Commercial Operations functions. He has been with Lupin since 2005 and has over 31 years of experience in the pharmaceutical industry. […]
Keren Haruvi (Chair)
Keren Haruvi is AAM Board Chair and President of Sandoz North America. In her role at Sandoz, she leads Sandoz’s largest commercial and country organization – the United States – which is responsible for approximately a quarter of the global revenue for Sandoz Inc. She also oversees Sandoz commercial operations in Canada, and is a member […]
Terry Fullem
Terry Fullem is the President of Strides Pharma Inc., the U.S. subsidiary of Strides Pharma Science Limited. He is responsible for the business operations of Strides entities in the U.S. Terry has over 25 years of experience in the pharmaceutical industry, including generics and brands. Prior to joining Strides, he was the President at Jubilant […]
Gretchen Fritz
Gretchen Fritz has been at American Regent since 2006 and is responsible for overseeing all legal and IP matters for American Regent, Inc. Prior to becoming Chief Legal Officer, Gretchen served in a number of legal positions across the Daiichi Sankyo Group in both the U.S. and Japan. Before joining the Daiichi Sankyo Group, Gretchen […]
Hafrun Fridriksdottir
Hafrun Fridriksdottir joined Hikma in April 2024 as President of Hikma’s Generics business. Prior to joining Hikma, Hafrun held senior executive roles at leading global pharmaceutical companies including Alvotech, Teva Pharmaceuticals, Allergan and Actavis, and most recently has served in advisory and board roles for several biotech and mid-sized pharma companies. Hafrun has MS Degree […]
Kevin Fortier
Kevin Fortier is the Chief Commercial Officer at Jubilant Cadista Pharmaceuticals, Inc. Kevin joined Cadista in April of 2014 as a National Account Director and has held roles of increasing responsibility during the past nine years. Kevin’s experience includes working for a wholesaler (Value Drug); a contract services company (now IQVIA); a retail pharmacy chain […]
Marc Falkin
Marc Falkin is the Chief Executive Officer for Cipla North America and is also a member of Cipla’s Management Council. He is based out of New Jersey and is responsible for leading Cipla’s ambitious plans in North America. Prior to being named the CEO in July 2024, he served as Cipla’s Chief Commercial Officer in North […]
Matthew Erick
Matthew Erick is the Chief Commercial Officer – Advanced Markets and is based in the U.S. Matt, who joined Biocon Biologics in 2022, is responsible for driving the commercial strategy and sales for Biocon Biologics in the advanced markets of North America, Europe, Japan, Australia and New Zealand. Matt will be working closely with partners […]
Dan Dischner
Dan Dischner serves as the Senior Vice President, Human Resources and Corporate Communications, at Amphastar Pharmaceuticals, Inc. Dan oversees all aspects of Amphastar’s communications efforts, including internal and external global communications, public relations, government affairs and corporate community responsibility. Additionally, in his role within Human Resources, Dan leads in the growth and professional development of employees […]
Victoria Wohlfeil Cherry
Victoria Wohlfeil Cherry is Meitheal’s General Counsel & Corporate Secretary since its inception in 2017. In addition, Victoria is the Corporate Secretary of Xentria, Inc. a biotech company focused on novel biologics and biosimilars, which was established in April 2020. Victoria came to Meitheal from Sagent Pharmaceuticals where she most recently served as Associate General Counsel and […]
Jeff Burd (Treasurer)
Jeff Burd is AAM Board Treasurer and President & CEO, North America, of Ajanta Pharma USA Inc., where he is responsible for the company’s strategy and all commercial operations in the United States. He has worked at Ajanta Pharma since 2013 and has more than 20 years of experience across the pharmaceutical industry. Prior to […]
Christine Baeder
Christine Baeder is the President of Apotex Corp and recently served as chair of the AAM board. Prior to joining Apotex, Christine spent over twenty years in senior roles with Organon Pharmaceuticals, Sandoz Inc., and most recently with Teva Pharmaceuticals as SVP and COO of the US Generics and Global Biosimilars business. Christine holds a BS […]
